LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.56234
 32.61 17.25 1470 2136 0.6881 0.8953
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.57 17.25 1255 2523 0.4974 0.8149
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.57 17.25 1568 2523 0.6215 0.8720
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.57 17.25 809 2523 0.3206 0.7074
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.57 17.25 1555 2523 0.6163 0.8698
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.54 17.25 1447 2679 0.5400 0.8377
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.54 17.25 1618 2679 0.6038 0.8661
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.54 17.25 1033 2679 0.3855 0.7545
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 36.54 17.25 1655 2679 0.6176 0.8719
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 38.51 17.25 1535 2906 0.5282 0.8346
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 38.51 17.25 1715 2906 0.5901 0.8624
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 38.51 17.25 1237 2906 0.4257 0.7819
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 38.51 17.25 1798 2906 0.6187 0.8743
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 40.48 17.25 1636 3125 0.5234 0.8346
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 40.48 17.25 1814 3125 0.5803 0.8601
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 40.48 17.25 1340 3125 0.4287 0.7865
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 40.48 17.25 1903 3125 0.6088 0.8720
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.45 17.25 1641 3504 0.4683 0.8116
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.45 17.25 1918 3504 0.5474 0.8488
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.45 17.25 1498 3504 0.4275 0.7902
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 42.45 17.25 2039 3504 0.5819 0.8636
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.42 17.25 1899 3895 0.4875 0.8244
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.42 17.25 2081 3895 0.5342 0.8459
MN20160310_N02
L07
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.42 17.25 1602 3895 0.4112 0.7851
MN20160310_N02
L09
MCF 10A-H2B-mCherry Dasatinib
0.56234
 44.42 17.25 2179 3895 0.5593 0.8568
MN20160310_N02
L09